MAS vs PPCB · P/E 18, rev $7.83B vs P/E 0.0, $3.9M cap
Masco Corporation (MAS) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
PPCB does not have a complete income-statement cache yet.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the MAS and PPCB stock pages for the full models.
Not investment advice.